Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Efficacy and safety of orally/sublingually, intranasally, and intraperitoneally administered recombinant murine interferon in the treatment of murine encephalomyocarditis virus.

Sonnenfeld G, Tovey M, Schellekens H, Kinney KS, Belay T, Morton DS, Austin CE, Reitman M, Fong TA, Vaughan HS.

J Interferon Cytokine Res. 2001 Jul;21(7):539-45.

PMID:
11506749
2.

SU6668 is a potent antiangiogenic and antitumor agent that induces regression of established tumors.

Laird AD, Vajkoczy P, Shawver LK, Thurnher A, Liang C, Mohammadi M, Schlessinger J, Ullrich A, Hubbard SR, Blake RA, Fong TA, Strawn LM, Sun L, Tang C, Hawtin R, Tang F, Shenoy N, Hirth KP, McMahon G, Cherrington.

Cancer Res. 2000 Aug 1;60(15):4152-60.

3.

Inhibition of tumor growth, angiogenesis, and microcirculation by the novel Flk-1 inhibitor SU5416 as assessed by intravital multi-fluorescence videomicroscopy.

Vajkoczy P, Menger MD, Vollmar B, Schilling L, Schmiedek P, Hirth KP, Ullrich A, Fong TA.

Neoplasia. 1999 Apr;1(1):31-41. Erratum in: Neoplasia 1999 Jun;1(2):183.

4.

Targeting angiogenesis inhibits tumor infiltration and expression of the pro-invasive protein SPARC.

Vajkoczy P, Menger MD, Goldbrunner R, Ge S, Fong TA, Vollmar B, Schilling L, Ullrich A, Hirth KP, Tonn JC, Schmiedek P, Rempel SA.

Int J Cancer. 2000 Jul 15;87(2):261-8.

5.

SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.

Fong TA, Shawver LK, Sun L, Tang C, App H, Powell TJ, Kim YH, Schreck R, Wang X, Risau W, Ullrich A, Hirth KP, McMahon G.

Cancer Res. 1999 Jan 1;59(1):99-106.

7.

Diversity of cytokine synthesis and function of mouse CD4+ T cells.

Mosmann TR, Schumacher JH, Street NF, Budd R, O'Garra A, Fong TA, Bond MW, Moore KW, Sher A, Fiorentino DF.

Immunol Rev. 1991 Oct;123:209-29. Review. No abstract available.

PMID:
1684780
8.

Inhibition of mouse macrophage degradation of acetyl-low density lipoprotein by interferon-gamma.

Fong LG, Fong TA, Cooper AD.

J Biol Chem. 1990 Jul 15;265(20):11751-60.

9.

Alloreactive murine CD8+ T cell clones secrete the Th1 pattern of cytokines.

Fong TA, Mosmann TR.

J Immunol. 1990 Mar 1;144(5):1744-52.

PMID:
2137843
10.

Heterogeneity of mouse helper T cells. Evidence from bulk cultures and limiting dilution cloning for precursors of Th1 and Th2 cells.

Street NE, Schumacher JH, Fong TA, Bass H, Fiorentino DF, Leverah JA, Mosmann TR.

J Immunol. 1990 Mar 1;144(5):1629-39.

PMID:
1968485
11.

The role of IFN-gamma in delayed-type hypersensitivity mediated by Th1 clones.

Fong TA, Mosmann TR.

J Immunol. 1989 Nov 1;143(9):2887-93.

PMID:
2530282
12.

Specific assays for cytokine production by T cells.

Mosmann TR, Fong TA.

J Immunol Methods. 1989 Jan 17;116(2):151-8.

PMID:
2642947

Supplemental Content

Support Center